NYSE: DPLO

-0.02 -0.36% $ 5.51 Volume: 104,483 Common Stock | 20 minute delay April 26, 2019

Improving Our Value by Improving Our Care

Diplomat (NYSE: DPLO) is the nation’s largest independent provider of specialty pharmacy and infusion services. Diplomat helps people with complex and chronic health conditions in all 50 states, partnering with payers, providers, hospitals, manufacturers, and more. Rooted in deep specialty-pharmacy expertise, Diplomat’s innovative service model unites complementary brands to anticipate market needs, create shareholder value, and drive better patient outcomes.

Date Filing Filing Description Download
April 24, 2019 DEFA14A Additional Proxy Soliciting Materials (definitive)
April 24, 2019 DEF 14A Proxy Statement (definitive)
April 22, 2019 8-K Current report filing

NYSE: DPLO

-0.02 -0.36% $ 5.51 Volume: 104,483 Common Stock | 20 minute delay April 26, 2019

Investor Contact

Terri Anne Powers,
Vice President, Investor Relations
Diplomat Pharmacy Inc.
tpowers@diplomat.is
Phone: 312.889.5244

Email Now